Targeting CD38/ ADP-ribosyl cyclase as a novel therapeutic strategy for identification of three potent agonists for leukopenia treatment
Leukopenia is the most common side effect of chemotherapy and radiotherapy. It potentially deteriorates into a life-threatening complication in cancer patients. Despite several agents being approved for clinical administration, there are still high incidences of pathogen-related disease due to a lac...
| Autori principali: | , , , , , , , , , , , , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Elsevier
2024-02-01
|
| Serie: | Pharmacological Research |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S1043661824000124 |